Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

ATRQβ-001 Vaccine Prevents Experimental Abdominal Aortic Aneurysms.

Zhang H, Liao M, Cao M, Qiu Z, Yan X, Zhou Y, Wu H, Wang Y, Zheng J, Ding J, Wang M, Liao Y, Chen X.

J Am Heart Assoc. 2019 Sep 17;8(18):e012341. doi: 10.1161/JAHA.119.012341. Epub 2019 Sep 12.

2.

RANKL-mediated osteoclastogenic differentiation of macrophages in the abdominal aorta of angiotensin II-infused apolipoprotein E knockout mice.

Tanaka T, Kelly M, Takei Y, Yamanouchi D.

J Vasc Surg. 2018 Dec;68(6S):48S-59S.e1. doi: 10.1016/j.jvs.2017.11.091. Epub 2018 Apr 21.

PMID:
29685509
3.

Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice.

Martorell S, Hueso L, Gonzalez-Navarro H, Collado A, Sanz MJ, Piqueras L.

Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1587-97. doi: 10.1161/ATVBAHA.116.307530. Epub 2016 Jun 9.

PMID:
27283745
4.

Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm.

Li Y, Lu G, Sun D, Zuo H, Wang DW, Yan J.

PLoS One. 2017 Apr 3;12(4):e0174821. doi: 10.1371/journal.pone.0174821. eCollection 2017.

5.

ATRQβ-001 vaccine prevents atherosclerosis in apolipoprotein E-null mice.

Zhou Y, Wang S, Qiu Z, Song X, Pan Y, Hu X, Zhang H, Deng Y, Ding D, Wu H, Yang S, Wang M, Zhou Z, Liao Y, Chen X.

J Hypertens. 2016 Mar;34(3):474-85; discussion 485. doi: 10.1097/HJH.0000000000000835.

PMID:
26771341
6.

Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy.

Ding D, Du Y, Qiu Z, Yan S, Chen F, Wang M, Yang S, Zhou Y, Hu X, Deng Y, Wang S, Wang L, Zhang H, Wu H, Yu X, Zhou Z, Liao Y, Chen X.

J Mol Med (Berl). 2016 Feb;94(2):207-18. doi: 10.1007/s00109-015-1343-6. Epub 2015 Sep 26.

7.

Effectiveness and safety of a therapeutic vaccine against angiotensin II receptor type 1 in hypertensive animals.

Chen X, Qiu Z, Yang S, Ding D, Chen F, Zhou Y, Wang M, Lin J, Yu X, Zhou Z, Liao Y.

Hypertension. 2013 Feb;61(2):408-16. doi: 10.1161/HYPERTENSIONAHA.112.201020. Epub 2012 Nov 26.

PMID:
23184378
8.

Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress.

Qin Y, Wang Y, Liu O, Jia L, Fang W, Du J, Wei Y.

Eur J Vasc Endovasc Surg. 2017 Mar;53(3):337-345. doi: 10.1016/j.ejvs.2016.10.026. Epub 2016 Nov 24.

9.

PARP-1 (Poly[ADP-Ribose] Polymerase 1) Inhibition Protects From Ang II (Angiotensin II)-Induced Abdominal Aortic Aneurysm in Mice.

Liang ES, Bai WW, Wang H, Zhang JN, Zhang F, Ma Y, Jiang F, Yin M, Zhang MX, Chen XM, Qin WD.

Hypertension. 2018 Nov;72(5):1189-1199. doi: 10.1161/HYPERTENSIONAHA.118.11184.

PMID:
30354818
10.

Hyperglycemia limits experimental aortic aneurysm progression.

Miyama N, Dua MM, Yeung JJ, Schultz GM, Asagami T, Sho E, Sho M, Dalman RL.

J Vasc Surg. 2010 Oct;52(4):975-83. doi: 10.1016/j.jvs.2010.05.086. Epub 2010 Aug 3.

11.

Dipeptidyl peptidase-4 inhibitor decreases abdominal aortic aneurysm formation through GLP-1-dependent monocytic activity in mice.

Lu HY, Huang CY, Shih CM, Chang WH, Tsai CS, Lin FY, Shih CC.

PLoS One. 2015 Apr 14;10(4):e0121077. doi: 10.1371/journal.pone.0121077. eCollection 2015.

12.

Knockdown of lncRNA PVT1 Inhibits Vascular Smooth Muscle Cell Apoptosis and Extracellular Matrix Disruption in a Murine Abdominal Aortic Aneurysm Model.

Zhang Z, Zou G, Chen X, Lu W, Liu J, Zhai S, Qiao G.

Mol Cells. 2019 Mar 31;42(3):218-227. doi: 10.14348/molcells.2018.0162. Epub 2019 Feb 1.

13.

PPARδ reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice by regulating extracellular matrix homeostasis and inflammatory responses.

Hwang JS, Kim HJ, Kim G, Kang ES, Ham SA, Yoo T, Paek KS, Yabe-Nishimura C, Kim HJ, Seo HG.

Int J Cardiol. 2014 Jun 1;174(1):43-50. doi: 10.1016/j.ijcard.2014.03.138. Epub 2014 Mar 21.

PMID:
24698256
14.

Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways.

Zhang XJ, He C, Tian K, Li P, Su H, Wan JB.

Vascul Pharmacol. 2015 Oct;73:86-95. doi: 10.1016/j.vph.2015.04.003. Epub 2015 Apr 22.

PMID:
25912763
15.

Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.

Tsai SH, Huang PH, Peng YJ, Chang WC, Tsai HY, Leu HB, Chen JW, Lin SJ.

Cardiovasc Res. 2013 Dec 1;100(3):501-10. doi: 10.1093/cvr/cvt230.

PMID:
24225494
16.

Rapamycin Treatment Attenuates Angiotensin II -induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity.

Li FF, Shang XK, Du XL, Chen S.

Curr Med Sci. 2018 Feb;38(1):93-100. doi: 10.1007/s11596-018-1851-z. Epub 2018 Mar 15.

PMID:
30074157
17.

Cathepsin G deficiency reduces periaortic calcium chloride injury-induced abdominal aortic aneurysms in mice.

Wang J, Sukhova GK, Liu J, Ozaki K, Lesner A, Libby P, Kovanen PT, Shi GP.

J Vasc Surg. 2015 Dec;62(6):1615-24. doi: 10.1016/j.jvs.2014.06.004. Epub 2014 Jul 16.

18.

SGLT-2 (Sodium-Glucose Cotransporter 2) Inhibition Reduces Ang II (Angiotensin II)-Induced Dissecting Abdominal Aortic Aneurysm in ApoE (Apolipoprotein E) Knockout Mice.

Ortega R, Collado A, Selles F, Gonzalez-Navarro H, Sanz MJ, Real JT, Piqueras L.

Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1614-1628. doi: 10.1161/ATVBAHA.119.312659. Epub 2019 Jul 11.

PMID:
31294626
19.

Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression.

Tedesco MM, Terashima M, Blankenberg FG, Levashova Z, Spin JM, Backer MV, Backer JM, Sho M, Sho E, McConnell MV, Dalman RL.

Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1452-7. doi: 10.1161/ATVBAHA.109.187757. Epub 2009 Jul 2.

20.

Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors.

Galán M, Varona S, Orriols M, Rodríguez JA, Aguiló S, Dilmé J, Camacho M, Martínez-González J, Rodriguez C.

Dis Model Mech. 2016 May 1;9(5):541-52. doi: 10.1242/dmm.024513. Epub 2016 Mar 17.

Supplemental Content

Support Center